APD trades 16.2% below Wall Street's consensus target of $325.63.
Last 12 months price action with 12-month analyst target path
The base valuation assumes APD achieves its forward estimates and maintains a stable P/E multiple of 21.2x. This scenario reflects the blended consensus of 42 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Air Products and Chemicals, Inc. (APD) has a Wall Street consensus price target of $325.63, based on estimates from 42 covering analysts. With the stock currently trading at $280.21, this represents a potential upside of +16.2%. The company has a market capitalization of $62.39B.
Analyst price targets range from a low of $285.00 to a high of $360.00, representing a 23% spread in expectations. The median target of $320.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 23 analysts rating the stock as a Buy or Strong Buy,19 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, APD trades at a trailing P/E of -158.3x and forward P/E of 21.2x. Analysts expect EPS to grow +39.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $113.20, with bear and bull scenarios of $71.32 and $149.15 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
LINLinde plc | $237.3B | $512.15 | $562.14 | +9.8% | Buy | 28.6x | 28 |
ALBAlbemarle Corporation | $18.9B | $160.35 | $209.75 | +30.8% | Hold | 13.2x | 45 |
PXP10, Inc. | $909M | $7.55 | $25.00 | +231.1% | Buy | 6.9x | 8 |
EMNEastman Chemical Company | $8.3B | $72.49 | $79.89 | +10.2% | Buy | 11.4x | 35 |
CECelanese Corporation | $5.7B | $51.16 | $65.60 | +28.2% | Hold | 8.3x | 37 |
OLNOlin Corporation | $2.5B | $22.01 | $28.30 | +28.6% | Hold | 271.4x | 35 |
HUNHuntsman Corporation | $2.1B | $12.07 | $13.80 | +14.3% | Hold | — | 33 |
WLKWestlake Corporation | $10.3B | $80.28 | $116.33 | +44.9% | Hold | 21.2x | 32 |
TROXTronox Holdings plc | $1.2B | $7.40 | $8.33 | +12.6% | Buy | — | 17 |
CATCaterpillar Inc. | $458.7B | $985.82 | $882.20 | -10.5% | Buy | 40.0x | 53 |
Quick answers to the most common questions about buying APD stock.
Air Products and Chemicals, Inc. (APD) has a consensus 12-month price target of $325.63, implying 16.2% upside from $280.21. The 42 analysts covering APD see moderate appreciation potential.
APD has a consensus rating of "Buy" based on 42 Wall Street analysts. The rating breakdown is predominantly bullish, with 23 Buy/Strong Buy ratings. The consensus 12-month price target of $325.63 implies 16.2% upside from current levels.
APD trades at a forward P/E of 21.2189x, representing a moderate valuation. With analysts targeting $325.63 (16.2% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $360 for APD, while the most conservative target is $285. The consensus of $325.63 represents the median expectation. Our quantitative valuation model projects a bull case target of $149 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
APD is heavily covered by Wall Street, with 42 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 23 have Buy ratings, 19 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month APD stock forecast based on 42 Wall Street analysts shows a consensus price target of $325.63, with estimates ranging from $285 (bear case) to $360 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $113, with bear/bull scenarios of $71/$149.
Our quantitative valuation model calculates APD's fair value at $113 (base case), with a bear case of $71 and bull case of $149. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
APD trades at a forward P/E ratio of 21.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on APD, with a "Buy" consensus rating and $325.63 price target (16.2% upside). 23 of 42 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
APD analyst price targets range from $285 to $360, a 23% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $325.63 consensus represents the middle ground. Our model's $71-$149 range provides an independent fundamental perspective.
Deep dive into APD consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.